NCT02659475View on ClinicalTrials.gov

Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED)

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

September 30, 2016

Conditions
Binge Eating Disorder
Interventions
DRUG

PHEN/TPM ER (Qsymia®)

PHEN/TPM ER (Qsymia®)

Trial Locations (1)

45040

Lindner Center of HOPE, Mason

All Listed Sponsors
collaborator

University of Cincinnati

OTHER

lead

Lindner Center of HOPE

OTHER

NCT02659475 - Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED) | Biotech Hunter | Biotech Hunter